GLUCAGON-ANALOGA
European patent · EP2875043 · In force
Register entry
- Publication number
- EP2875043
- Application number
- EP13756832
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 23, 2013
- Published
- May 27, 2015
- Granted
- Dec 21, 2016
- Protection ends at the latest
- Jul 22, 2033
- Next annual fee due
- Jul 31, 2027
- IPC classes
- C07K 14/605 (2006.01)C12N 1/15 (2006.01)C12N 1/21 (2006.01)C12N 5/10 (2006.01)A61K 38/26 (2006.01)//A61K 38/00 (2006.01)
- Priority
- US 201261674706 P 23.07.2012US 201361785611 P 14.03.2013DK 201300360 14.06.2013
- PCT application
- PCT/EP2013/065519 23.07.2013
- PCT publication
- WO2014/016300 30.01.2014
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.07.2026 → 31.07.2027
Published in Swissreg on 01.08.2026
- Aug 6, 2025
Next annual fee due on
- Next annual fee due on
- 31.07.2025 → 31.07.2026
Published in Swissreg on 06.08.2025
- Sep 3, 2024
Holder’s address changed
- Owner
- Zealand Pharma A/S, Smedeland 36, 2600 Glostrup, Denmark → Zealand Pharma A/S, Sydmarken 11, 2860 Søborg, Denmark
Published in Swissreg on 03.09.2024
- Sep 2, 2024
Agent entered
- Representative
- MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex
Published in Swissreg on 02.09.2024
- Aug 1, 2024
Change
Published in Swissreg on 01.08.2024
- Aug 1, 2023
Change
Published in Swissreg on 01.08.2023
- Aug 1, 2022
Change
Published in Swissreg on 01.08.2022
- Dec 21, 2016
Granted
Published in Swissreg on 21.12.2016
Parties
Inventor
DK-2700 Brønshøj, DK
DK-2000 Frederiksberg, DK
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.